Auriclosene: Completed Phase IIb enrollment

NovaBay completed enrollment of about 450 patients in the double-blind, placebo-controlled, international Phase IIb BAYnovation trial evaluating auriclosene ophthalmic solution for 10 days. NovaBay pl...